News US regulator grants $23 million to rare disease R&D FDA announces 21 rare disease clinical trial research grants.
News EU regulator recommends Intercept's potential liver blockbus... Sales forecast to reach $2.6 billion in 2020.
News Alnylam plunges after deaths in rare disease trial Biotech axes revusiran due to safety concerns.
News Faron moves ahead with "shock lung" drug Finnish firm eyes first drug for acute respiratory distress syndrome.
News US and EU regulators collaborate on rare diseases Clinical trial design among areas regulators will collaborate on
News Zafgen ends development of Prader-Willi drug Share price plummets after biotech said drug is unsafe.
News RFK Jr revives childhood vaccine task force HHS Secretary Kennedy adds yet another layer of scrutiny to childhood vaccines with the re-establishment of a task force disbanded in the 1990s.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
